<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00300157</url>
  </required_header>
  <id_info>
    <org_study_id>2004-06</org_study_id>
    <nct_id>NCT00300157</nct_id>
  </id_info>
  <brief_title>Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent</brief_title>
  <official_title>French Multicenter Study Assessing Angioplasty With Taxus Drug Eluting Stent in Unprotected Left Main Coronary Artery Associated to Other Coronary Lesions or Not</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether percutaneous coronary angioplasty with&#xD;
      Taxus drug eluting stent is safe and effective in the treatment of unprotected left main&#xD;
      coronary artery disease associated to other coronary lesions or not.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary artery bypass graft is the reference treatment of left main coronary artery disease.&#xD;
      With the advancements of technology and particularly drug-eluting stents, in-stent restenosis&#xD;
      has dramatically decreased and now it is possible to extend indications of complexes lesions&#xD;
      such as left main coronary artery stenoses. In these particular situations,some centers&#xD;
      performed percutaneous coronary angioplasty (PCI) with drug-eluting stents with acceptable&#xD;
      results in terms of safety and efficacy. However, these procedures are performed at isolated&#xD;
      sites and are not evaluated in multicenter trial.The aim of this study is to assess the&#xD;
      safety and efficacy of this PCI with Taxus-stent in a french multicenter trial and to&#xD;
      evaluate clinical and angiographic outcome of these patients at long-term follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Coronarography</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major cardio-vascular events</measure>
    <time_frame>1, 18 and 36 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">155</enrollment>
  <condition>Coronary Arteriosclerosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous coronary intervention with Taxus stent</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient must be &gt; or = 18 years of age&#xD;
&#xD;
          -  Patient must provide written informed consent prior to the procedure using a form that&#xD;
             is approved by the local Ethics Committee&#xD;
&#xD;
          -  Aspirin + Clopidogrel &gt; or = 12 hours before percutaneous coronary intervention (PCI)&#xD;
&#xD;
          -  Documented evidence of ischemic heart disease (clinical,biological or ECG) with&#xD;
             unprotected left main coronary artery stenosis &gt; or = 50% associated to other coronary&#xD;
             lesions or not responsible of stable or unstable coronary syndrome above 48 hours&#xD;
&#xD;
          -  The target reference vessel diameter must be &gt; or = 2.5 mm&#xD;
&#xD;
          -  Unprotected left main coronary artery disease eligible by coronary stenting&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Restenosis lesion in left main coronary artery&#xD;
&#xD;
          -  Known allergies to the following: aspirin, clopidogrel,ticlopidine,contrast agent or&#xD;
             drug similar to paclitaxel&#xD;
&#xD;
          -  Acute coronary syndrome &lt; 48 hours&#xD;
&#xD;
          -  Impaired renal function (creatinine &gt; 180 ùmol/l) at the time of treatment&#xD;
&#xD;
          -  Life expectancy less than 36 months&#xD;
&#xD;
          -  Female of childbearing potential without reliable birth control&#xD;
&#xD;
          -  Currently participating in an investigational drug or device study that has not&#xD;
             completed the primary endpoint or that clinically interferes with the study endpoints&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier Carrié, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rangueil Hospital Toulouse France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hélène ELTCHANINOFF, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Charles Nicolle Rouen FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thierry LEFEVRE, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Jacques Cartier ICPS Massy FRANCE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc SILVESTRI, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Polyclinique du Parc Rambot Aix en Provence FRANCE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Polyclinique du Parc Rambot</name>
      <address>
        <city>Aix-en-Provence</city>
        <zip>13100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Rhône Durance</name>
      <address>
        <city>Avignon</city>
        <zip>84082</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Augustin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU CAEN</name>
      <address>
        <city>CAEN Cedex</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Cardiologique</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Tonkin</name>
      <address>
        <city>Lyon</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unité Cardio-Vasculaire</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU NORD</name>
      <address>
        <city>Marseille</city>
        <zip>13326</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Hospitalier Jacques Cartier-ICPS</name>
      <address>
        <city>Massy</city>
        <zip>91300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Bon Secours</name>
      <address>
        <city>Metz</city>
        <zip>57000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Millénaire</name>
      <address>
        <city>Montpellier</city>
        <zip>34960</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nouvelles Cliniques Nantaises</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital privé Les Franciscaines</name>
      <address>
        <city>Nimes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Caremeau</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital COCHIN</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Mutualiste Montsouris</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier La Pitié-Salpetrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Hilaire</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Arnaud Tzanck</name>
      <address>
        <city>Saint Laurent du Var</city>
        <zip>06700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Cardiologique du Nord</name>
      <address>
        <city>Saint-Denis</city>
        <zip>93200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Gatien</name>
      <address>
        <city>Tours</city>
        <zip>37042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <study_first_submitted>March 7, 2006</study_first_submitted>
  <study_first_submitted_qc>March 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2006</study_first_posted>
  <last_update_submitted>January 3, 2011</last_update_submitted>
  <last_update_submitted_qc>January 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Didier Carrié</name_title>
    <organization>Rangueil Hospital</organization>
  </responsible_party>
  <keyword>Left main coronary artery stenosis, stent, Taxus</keyword>
  <keyword>Unprotected left main coronary artery disease</keyword>
  <keyword>Percutaneous coronary intervention with Taxus stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

